BEGIN:VCALENDAR
VERSION:2.0
METHOD:PUBLISH
PRODID:-//Telerik Inc.//Sitefinity CMS 14.4//EN
BEGIN:VTIMEZONE
TZID:Central Standard Time
BEGIN:STANDARD
DTSTART:20251102T020000
RRULE:FREQ=YEARLY;BYDAY=1SU;BYHOUR=2;BYMINUTE=0;BYMONTH=11
TZNAME:Central Standard Time
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
END:STANDARD
BEGIN:DAYLIGHT
DTSTART:20250301T020000
RRULE:FREQ=YEARLY;BYDAY=2SU;BYHOUR=2;BYMINUTE=0;BYMONTH=3
TZNAME:Central Daylight Time
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
DESCRIPTION:PFF Chief Medical Officer Dr. Amy Hajari Case and Senior Medica
 l Advisor Dr. Sonye Danoff will discuss examples of research conducted by 
 the NIH and how NIH funding supports development of new treatments for PF.
  The NIH is a crucial driver in PF research advancements and this timely p
 resentation will shed light on the buzzwords that have been mentioned in t
 he national news over the past few months.
DTEND:20250423T180000Z
DTSTAMP:20260611T043046Z
DTSTART:20250423T170000Z
LOCATION:
SEQUENCE:0
SUMMARY:Research at risk: Understanding the critical role of the NIH in fin
 ding new treatments for PF | Virtual
UID:RFCALITEM639167310463924822
X-ALT-DESC;FMTTYPE=text/html:PFF Chief Medical Officer Dr. Amy Hajari Case 
 and Senior Medical Advisor Dr. Sonye Danoff will discuss examples of resea
 rch conducted by the NIH and how NIH funding supports development of new t
 reatments for PF. The NIH is a crucial driver in PF research advancements 
 and this timely presentation will shed light on the buzzwords that have be
 en mentioned in the national news over the past few months.
END:VEVENT
END:VCALENDAR